Challenges in managing genetic cancer risk: A long-term qualitative study of unaffected women carrying BRCA1/BRCA2 mutations

Genetics in Medicine

Volumn 17, Issue 9, 2015, Pages 726-732

  Caiata Zufferey, Maria ^a   Pagani, Olivia ^b   Cina, Viviane ^c   Membrez, Véronique ^d   Taborelli, Monica ^b   Unger, Sheila ^c   Murphy, Anne ^e   Monnerat, Christian ^f   Chappuis, Pierre O ^d,e  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d Hopital du Valais   (Switzerland)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^f Hopital du Jura   (Switzerland)

Author keywords

BRCA1 BRCA2; challenges; preventive medicine; qualitative research; risk management

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; BRCA1 PROTEIN, HUMAN; BRCA2 PROTEIN, HUMAN;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL ARTICLE; FEMALE; GENE MUTATION; GENETIC RISK; GENETIC SCREENING; HEALTH PROGRAM; HUMAN; OVARY CANCER; PRACTICE GUIDELINE; QUALITATIVE RESEARCH; RISK REDUCTION; SWITZERLAND; BREAST NEOPLASMS; GENETIC PREDISPOSITION; GENETICS; GERMLINE MUTATION; HEALTH PERSONNEL ATTITUDE; LONGITUDINAL STUDY; MIDDLE AGED; PSYCHOLOGIC TEST; PSYCHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; TUMOR SUPPRESSOR GENE;

ADULT; ATTITUDE OF HEALTH PERSONNEL; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GERM-LINE MUTATION; GUIDELINE ADHERENCE; HUMANS; INTERVIEW, PSYCHOLOGICAL; LONGITUDINAL STUDIES; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84940924412     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2014.183     Document Type: Article

References (36)

1. Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-1130.
2. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 2007;25:1329-1333.
3. Mavaddat N, Peock S, Frost D, et al.; EMBRACE. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 2013;105:812-822.
4. American College of Obstetricians and Gynecologists Committee. ACOG practice bulletin no. 103: hereditary breast and ovarian cancer syndrome. Obstet Gynecol 2009;113:957-966.
5. Daly MB, Axilbund JE, Buys S, et al.; National Comprehensive Cancer Network. Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw 2010;8:562-594.
6. Balmaña J, Díez O, Rubio IT, Cardoso F; ESMO Guidelines Working Group. BRCA in breast cancer: ESMO clinical practice guidelines. Ann Oncol 2011;22(suppl 6):vi31-vi34.
7. Evans DG, Graham J, O'Connell S, Arnold S, Fitzsimmons D. Familial breast cancer: summary of updated NICE guidance. BMJ 2013;346:f3829.
8. Clarke A. The process of genetic counselling. In: Harper P, Clarke A, (eds). Genetics, Society and Clinical Practice. BIOS Scientific Publishers: Oxford, UK, 1997:179-200.
9. Lemke T, ed. Perspectives on Genetic Discrimination. Taylor & Francis: New York, 2013.
10. Meiser B. Psychological impact of genetic testing for cancer susceptibility: An update of the literature. Psychooncology 2005;14:1060-1074.
11. Halbert CH, Stopfer JE, McDonald J, et al. Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns? J Clin Oncol 2011;29:4302-4306.
12. Metcalfe KA, Mian N, Enmore M, et al. Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening. Breast Cancer Res Treat 2012;133:735-740.
13. van Oostrom I, Meijers-Heijboer H, Lodder LN, et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: A 5-year follow-up study. J Clin Oncol 2003;21:3867-3874.
14. Watson M, Foster C, Eeles R, et al.; Psychosocial Study Collaborators. Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. Br J Cancer 2004;91:1787-1794.
15. Dagan E, Shochat T. Quality of life in asymptomatic BRCA1/2 mutation carriers. Prev Med 2009;48:193-196.
16. Graves KD, Vegella P, Poggi EA, et al. Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice. Cancer Epidemiol Biomarkers Prev 2012;21:445-455.
17. Claes E, Denayer L, Evers-Kiebooms G, Boogaerts A, Legius E. Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact. Patient Educ Couns 2004;55:265-274.
18. Bertaux D. Biography and Society: The Life History Approach in the Social Sciences. Sage: London, 1981.
19. Strauss A, Corbin J, eds. Basics of Qualitative Research: Grounded Theory Procedures and Techniques. Sage: Newbury Park, CA, 1990.
20. Kenen RH. The at-risk health status and technology: A diagnostic invitation and the 'gift' of knowing. Soc Sci Med 1996;42:1545-1553.
21. d'Agincourt-Canning L. Experiences of genetic risk: disclosure and the gendering of responsibility. Bioethics 2001;15:231-247.
22. Lau Y, Jaye C. The 'obligation' to screen and its effect on autonomy. J Bioeth Inq 2009;6:495-505.
23. Ferrell BR, Smith SL, Ervin KS, Itano J, Melancon C. A qualitative analysis of social concerns of women with ovarian cancer. Psychooncology 2003;12:647-663.
24. Hamilton R, Williams JK, Bowers BJ, Calzone K. Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer. J Genet Couns 2009;18:147-159.
25. Escher M, Sappino AP. Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition. Ann Oncol 2000;11:1131-1135.
26. Pichert G, Dietrich D, Moosmann P, Zwahlen M, Stahel RA, Sappino AP. Swiss primary care physicians' knowledge, attitudes and perception towards genetic testing for hereditary breast cancer. Fam Cancer 2003;2:153-158.
27. Bellcross CA, Kolor K, Goddard KA, Coates RJ, Reyes M, Khoury MJ. Awareness and utilization of BRCA1/2 testing among U. S. primary care physicians. Am J Prev Med 2011;40:61-66.
28. Feero WG, Green ED. Genomics education for health care professionals in the 21st century. JAMA 2011;306:989-990.
29. Nippert I, Harris HJ, Julian-Reynier C, et al. Confidence of primary care physicians in their ability to carry out basic medical genetic tasks-a European survey in five countries-Part 1. J Community Genet 2011;2:1-11.
30. Trivers KF, Baldwin LM, Miller JW, et al. Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: A vignette-based study. Cancer 2011;117:5334-5343.
31. Weitzel JN, Blazer KR, Macdonald DJ, Culver JO, Offit K. Genetics, genomics, and cancer risk assessment: state of the art and future directions in the era of personalized medicine. CA Cancer J Clin 2011;61:327-359.
32. Godlee F. Preventive medicine makes us miserable. BMJ 2005;330:7497.
33. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282: 1458-1465.
34. Löwy I, Gaudillière JP. Localizing the global. Testing for hereditary risk for breast cancer. Sci Technol Human Values 2008;33:299-325.
35. Kenen RH, Shapiro PJ, Friedman S, Coyne JC. Peer-support in coping with medical uncertainty: discussion of oophorectomy and hormone replacement therapy on a web-based message board. Psychooncology 2007;16: 763-771.
36. Hughes L, Phelps C. "The bigger the network the bigger the bowl of cherries. ": exploring the acceptability of, and preferences for, an ongoing support network for known BRCA 1 and BRCA 2 mutation carriers. J Genet Couns 2010;19: 487-496.